Atsufumi Kawabata Selected Research

Atsufumi Kawabata Research Topics

Disease

55	Hyperalgesia 06/2023 - 06/2002
42	Pain (Aches) 01/2024 - 06/2003
17	Visceral Pain 01/2023 - 03/2004
12	Peripheral Nervous System Diseases (PNS Diseases) 01/2024 - 01/2016
12	Neoplasms (Cancer) 01/2023 - 06/2012
12	Cystitis 01/2023 - 06/2011
11	Inflammation (Inflammations) 01/2023 - 12/2003
10	Pancreatitis 01/2023 - 05/2006
9	Hypersensitivity (Allergy) 01/2023 - 07/2006
8	Neuralgia (Stump Neuralgia) 01/2023 - 07/2010
6	Intractable Pain 12/2022 - 01/2011
5	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 10/2015
5	Nociceptive Pain 01/2019 - 11/2010
4	Interstitial Cystitis (Interstitial Cystitis, Chronic) 06/2020 - 06/2011
4	Edema (Dropsy) 01/2018 - 08/2006
3	Hypertension (High Blood Pressure) 01/2021 - 07/2004
2	Wounds and Injuries (Trauma) 01/2023 - 01/2020
2	Multiple Myeloma 01/2021 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 12/2008
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2020 - 05/2020
2	Disseminated Intravascular Coagulation 01/2019 - 11/2013
2	Referred Pain 01/2018 - 01/2012
2	Hyperthermia 01/2017 - 01/2017

Drug/Important Bio-Agent (IBA)

17	HMGB1 Protein (HMG1)IBA 01/2022 - 11/2013
16	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2019 - 11/2007
15	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2023 - 03/2009
13	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 06/2011
13	ThrombomodulinIBA 05/2021 - 11/2013
12	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 06/2002
11	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 06/2012
11	sodium bisulfide (NaHS)IBA 01/2019 - 11/2007
10	CeruletideIBA 01/2023 - 05/2006
9	Protein Isoforms (Isoforms)IBA 12/2022 - 07/2012
9	Proteins (Proteins, Gene)FDA Link 12/2020 - 03/2009
8	GasotransmittersIBA 01/2023 - 11/2007
8	Thrombin FDA Link 01/2021 - 06/2002
7	EnzymesIBA 01/2023 - 11/2007
7	LyasesIBA 01/2023 - 10/2012
7	CystathionineIBA 01/2023 - 10/2012
7	NNC 55-0396IBA 06/2019 - 01/2012
5	sodium sulfideIBA 01/2023 - 02/2014
5	Cysteine (L-Cysteine)FDA Link 01/2023 - 11/2007
5	Receptor for Advanced Glycation End ProductsIBA 01/2021 - 04/2014
4	ZincIBA 06/2023 - 02/2015
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2022 - 01/2018
4	Toll-Like Receptor 4IBA 01/2021 - 04/2014
4	Nuclear Proteins (Protein, Nuclear)IBA 01/2021 - 11/2013
4	Neutralizing AntibodiesIBA 12/2020 - 11/2013
4	Capsaicin (Zostrix)FDA Link 05/2020 - 06/2003
4	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2019 - 06/2012
4	ProstaglandinsIBA 01/2018 - 01/2011
4	Phenobarbital (Luminal)FDA Link 01/2018 - 03/2004
4	LipopolysaccharidesIBA 01/2018 - 04/2014
4	Analgesics (Analgesic Drugs)IBA 01/2016 - 08/2006
4	MibefradilIBA 10/2012 - 11/2007
3	Calcium Channels (Calcium Channel)IBA 01/2023 - 01/2018
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 08/2006
3	Hormones (Hormone)IBA 01/2021 - 01/2019
3	Dihydrotachysterol (AT 10)IBA 01/2021 - 08/2006
3	Bortezomib (Velcade)FDA Link 01/2021 - 01/2019
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2020 - 04/2014
3	capsazepineIBA 05/2020 - 06/2002
3	AndrogensIBA 01/2019 - 10/2015
3	Minocycline (Cyclops)FDA LinkGeneric 10/2018 - 01/2017
3	2-furoyl-LIGRLO-amideIBA 01/2018 - 05/2006
3	TrypsinIBA 05/2007 - 09/2003
3	seryl- leucyl- isoleucyl- glycyl- - arginyl- leucinamideIBA 07/2006 - 06/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2003 - 09/2002
2	N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA 06/2023 - 01/2018
2	Chelating AgentsIBA 06/2023 - 01/2018
2	Sulfides (Thioethers)IBA 01/2023 - 10/2009
2	Antipsychotic Agents (Antipsychotics)IBA 01/2023 - 01/2021
2	Pimozide (Orap)FDA Link 12/2022 - 01/2021
2	AlbuminsIBA 01/2022 - 01/2019
2	C-Reactive ProteinIBA 01/2022 - 01/2019
2	Estrogens (Estrogen)FDA Link 05/2021 - 01/2021
2	Butyrates (Butyrate)IBA 02/2021 - 11/2020
2	Bepridil (Vascor)FDA Link 01/2021 - 01/2021
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 01/2019
2	Vincristine (Oncovin)FDA LinkGeneric 12/2020 - 01/2016
2	PAR-2 ReceptorIBA 11/2020 - 11/2010
2	Substance PIBA 06/2020 - 01/2018
2	Immunosuppressive Agents (Immunosuppressants)IBA 05/2020 - 01/2017
2	Tacrolimus (Prograf)FDA LinkGeneric 05/2020 - 01/2017
2	Calcineurin InhibitorsIBA 05/2020 - 01/2017
2	CalcineurinIBA 05/2020 - 01/2017
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2020 - 10/2018
2	AntioxidantsIBA 01/2020 - 02/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2017
2	AsparagineIBA 01/2019 - 01/2017
2	Dacarbazine (DIC)FDA LinkGeneric 01/2019 - 11/2013
2	ethyl pyruvateIBA 10/2018 - 12/2017
2	Clodronic Acid (Clodronate)IBA 10/2018 - 12/2017
2	prolinedithiocarbamate (PDTC)IBA 10/2018 - 01/2018
2	Alanine (L-Alanine)FDA Link 01/2018 - 01/2018
2	CurcuminIBA 01/2018 - 01/2010

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 03/2022 - 02/2013
6	Therapeutics 01/2022 - 11/2004
2	Ligation 01/2018 - 01/2018
2	Injections 12/2017 - 12/2015